CND Pharma

CND Pharma is a South Korean specialty pharmaceutical company dedicated to providing innovative treatments for rare and orphan diseases. Founded in 2007, the company focuses on the licensing, registration, and commercialization of global breakthrough medicines within the Korean market. CND Pharma maintains strategic partnerships with international biotech and pharmaceutical firms to bridge the gap for patients with high unmet medical needs. Their portfolio primarily includes therapies for metabolic disorders and other specialized conditions, such as Fabry disease and Phenylketonuria. The company provides comprehensive services including regulatory affairs, market access, and specialized distribution. By acting as a local representative for global firms, CND Pharma ensures that life-saving treatments navigate the complex South Korean healthcare landscape effectively.